ImmunityBio Inc. Common Stock vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? ImmunityBio Inc. Common Stock trades at $10.69 (market cap $10.51B), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.71 (market cap $58.74B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is far larger — about 5.6× ImmunityBio Inc. Common Stock's market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays a 3.33% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 1 Days and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 1 Days on average.
| IBRX | TAK | |
|---|---|---|
Market Cap | $10.51B | $58.74B |
Volume | 10,445,785 | 3,110,994 |
Sector | Health | Health |
52-Week High | $11.55 | $19.05 |
52-Week Low | $1.98 | $13.23 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $10.97B | $86.65B |
Dividend Yield | — | 3.33% |
Trailing returns across standard periods
Latest headlines on both assets
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →